Literature DB >> 27147334

MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.

Soumya Ghose1, Jhimli Mitra1, David Rivest-Hénault2, Amir Fazlollahi2, Peter Stanwell3, Peter Pichler4, Jidi Sun5, Jurgen Fripp2, Peter B Greer5, Jason A Dowling2.   

Abstract

PURPOSE: The feasibility of radiation therapy treatment planning using substitute computed tomography (sCT) generated from magnetic resonance images (MRIs) has been demonstrated by a number of research groups. One challenge with an MRI-alone workflow is the accurate identification of intraprostatic gold fiducial markers, which are frequently used for prostate localization prior to each dose delivery fraction. This paper investigates a template-matching approach for the detection of these seeds in MRI.
METHODS: Two different gradient echo T1 and T2* weighted MRI sequences were acquired from fifteen prostate cancer patients and evaluated for seed detection. For training, seed templates from manual contours were selected in a spectral clustering manifold learning framework. This aids in clustering "similar" gold fiducial markers together. The marker with the minimum distance to a cluster centroid was selected as the representative template of that cluster during training. During testing, Gaussian mixture modeling followed by a Markovian model was used in automatic detection of the probable candidates. The probable candidates were rigidly registered to the templates identified from spectral clustering, and a similarity metric is computed for ranking and detection.
RESULTS: A fiducial detection accuracy of 95% was obtained compared to manual observations. Expert radiation therapist observers were able to correctly identify all three implanted seeds on 11 of the 15 scans (the proposed method correctly identified all seeds on 10 of the 15).
CONCLUSIONS: An novel automatic framework for gold fiducial marker detection in MRI is proposed and evaluated with detection accuracies comparable to manual detection. When radiation therapists are unable to determine the seed location in MRI, they refer back to the planning CT (only available in the existing clinical framework); similarly, an automatic quality control is built into the automatic software to ensure that all gold seeds are either correctly detected or a warning is raised for further manual intervention.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27147334     DOI: 10.1118/1.4944871

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

Review 1.  Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.

Authors:  Kaustav Bera; Vamsidhar Velcheti; Anant Madabhushi
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

Review 2.  MRI-only treatment planning: benefits and challenges.

Authors:  Amir M Owrangi; Peter B Greer; Carri K Glide-Hurst
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

3.  Comparison of MRI sequences in ideal fiducial maker-based radiotherapy for prostate cancer.

Authors:  Osamu Tanaka; Hisao Komeda; Mitsuyoshi Hattori; Shigeki Hirose; Eiichi Yama; Masayuki Matsuo
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-01

4.  Are cone beam CT image matching skills transferrable from planning CT to planning MRI for MR-only prostate radiotherapy?

Authors:  Rachel L Brooks; Hazel M McCallum; Rachel A Pearson; Karen Pilling; Jonathan Wyatt
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.039

5.  Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.

Authors:  Matteo Maspero; Peter R Seevinck; Nicole J W Willems; Gonda G Sikkes; Geja J de Kogel; Hans C J de Boer; Jochem R N van der Voort van Zyp; Cornelis A T van den Berg
Journal:  Radiat Oncol       Date:  2018-06-05       Impact factor: 3.481

6.  MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.

Authors:  Emilia Persson; Christian Jamtheim Gustafsson; Petra Ambolt; Silke Engelholm; Sofie Ceberg; Sven Bäck; Lars E Olsson; Adalsteinn Gunnlaugsson
Journal:  Radiat Oncol       Date:  2020-04-09       Impact factor: 3.481

7.  Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.

Authors:  Christian Gustafsson; Emilia Persson; Adalsteinn Gunnlaugsson; Lars E Olsson
Journal:  J Appl Clin Med Phys       Date:  2018-10-24       Impact factor: 2.102

8.  Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.

Authors:  Angela U Pathmanathan; Helen A McNair; Maria A Schmidt; Douglas H Brand; Louise Delacroix; Cynthia L Eccles; Alexandra Gordon; Trina Herbert; Nicholas J van As; Robert A Huddart; Alison C Tree
Journal:  Br J Radiol       Date:  2019-01-24       Impact factor: 3.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.